Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I. Volmer
122P Pathological Response Rates After Induction Radio-Chemotherapy in Stage III NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
The Survival Impact of Delayed Surgery and Adjuvant Chemotherapy on Stage II/III Rectal Cancer With Pathological Complete Response After Neoadjuvant Chemoradiation
International Journal of Cancer
Cancer Research
Oncology
Molecular Apocrine Tumours in EORTC 10994/Big 1-00 Phase III Study: Pathological Response After Neoadjuvant Chemotherapy and Clinical Outcomes
British Journal of Cancer
Cancer Research
Oncology
Inflammatory Breast Recurrence After Preoperative Chemotherapy Followed by Pathological Complete Response
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
VATS Pneumonectomy After Induction Chemotherapy
Journal of Clinical and Analytical Medicine
Medicine
P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFRm-Positive Stage III NSCLC (LAURA)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PL02.01 Overall Survival With Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results From PACIFIC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
